Zealand Pharma shared positive trial results for its dasiglucagon – 99% of participants recovered from hypo within 15 minutes of treatment
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
41 readers recommended
The latest on Dexcom’s work with Verily to make a more simple and accessible CGM; also, the “Pro Q” professional CGM and insulin dosing advice for people on multiple...
39 readers recommended
Xeris’ Glucagon Rescue Pen, designed as an auto-injector, features a ready-to-use liquid glucagon – a safer and more convenient treatment option for severe hypoglycemia
37 readers recommended
Results from the CREDENCE trial suggest that Invokana’s kidney benefits exist on top of blood pressure lowering medications (standard of care)
29 readers recommended
Insightful diabetes leaders discuss high-potential areas ranging from SGLT-2s in type 1 diabetes, personalized treatment plans, and the do-it-yourself Loop app
31 readers recommended
Sanofi covers all insulins under this program, including Toujeo, Lantus, Admelog, Apidra.
24 readers recommended
A new study will investigate whether SGLT-2 inhibitor Farxiga can delay the progression of heart failure in people with and without type 2 diabetes
27 readers recommended
Surprising study findings from a look at refrigerator temperatures and the risk posed to insulin quality; plus, a guide to safe insulin storage and Med Angel’s very cool...
34 readers recommended
CVS now offers same-day prescription home delivery from 6,000 pharmacies across the United States for a delivery charge of $7.99.
32 readers recommended
A study is enrolling over 100 people with type 2 between the ages of 10 and 18 years, examining Jardiance and Tradjenta
36 readers recommended
The study aims to enroll about 1,800 adults with type 2 diabetes at increased risk of heart disease
35 readers recommended
The EMA approved Zynquista (sotagliflozin), an SGLT-1/2 dual inhibitor, for adults with a BMI above 27
24 readers recommended
The most promising therapies in the pipeline, accuracy data on the FreeStyle Libre 2, and more
30 readers recommended
For now, another SGLT-2 inhibitor pill already approved for people with type 2 diabetes is not approved for people with type 1 diabetes in the US. The drug was recently...
22 readers recommended
Farxiga’s heart health benefits were the same in people with and without diabetes, as well as across a spectrum of baseline A1C levels
35 readers recommended
A new premixed, liquid glucagon coming in October in a prefilled syringe and in 2020 as an auto-injector. The second stable glucagon approved this year
28 readers recommended
By Becky Milner A company called Intarcia has developed a GLP-1 mini-pump that is implanted under the skin to continuously provide medication for six months at a time –...
25 readers recommended
These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments
24 readers recommended
New guidelines from ADA and EASD focus on GLP-1 agonists and SGLT-2 inhibitors to improve heart and kidney health
25 readers recommended
Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...